A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects with Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

Trial Identifier: D6830C00001
Sponsor: AstraZeneca
NCTID:: NCT05110976
Start Date: December 2021
Primary Completion Date: August 2023
Study Completion Date: August 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translations
English Translation

Trial Locations

Country Location
DE Berlin, DE, 10119
DE Frankfurt, DE, 60596
DE Gro�hansdorf, DE, 22927
DE L�beck, DE, 23552
DE Magdeburg, DE, 39120
DE Wiesbaden, DE, 65187
GB Bradford, GB, BD9 6RJ
GB London, GB, HA1 3UJ
GB Manchester, GB, M23 9QZ
GB Portsmouth, GB, PO6 3LY
US, CA Bakersfield, CA, US, 93301
US, CA Glendale, CA, US, 91206
US, CA San Jose, CA, US, 95117
US, FL Homestead, FL, US, 33030
US, FL Miami, FL, US, 33173
US, FL Miami, FL, US, 33122
US, ID Boise, ID, US, 83706
US, MA North Dartmouth, MA, US, 02747
US, MD White Marsh, MD, US, 21162
US, NC Raleigh, NC, US, 27607
US, TX El Paso, TX, US, 79903